Key clinical point: Patients with migraine who undergo surgery often need to use a migraine abortive drug perioperatively.

Major finding: Adjusted 30-day hospital readmissions for pain were 36% lower in patients prescribed a migraine abortive agent perioperatively.

Study details: Review of observational data from 21,932 U.S. migraine patients who underwent surgery.

Disclosures: Dr. Platzbecker had no commercial disclosures.